# Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment

> **NCT03803293** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 11098 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DIAGNOSTIC_TEST:** Pharmacogenomic testing

## Key facts

- **NCT ID:** NCT03803293
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-13
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 11098 (ACTUAL)
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03803293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03803293, "Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03803293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*